Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

被引：0
|
作者：
Srour, Samer A. [1 ]
Milton, Denai [1 ]
Bashir, Qaiser [1 ]
Mehta, Rohtesh S. [1 ]
Delgado, Ruby [1 ]
Rondon, Gabriela [1 ]
Nieto, Yago [1 ]
Hosing, Chitra M. [1 ]
Popat, Uday R. [1 ]
Ciurea, Stefan O. [1 ]
Patel, Krina [2 ]
Lee, Hans C. [2 ]
Manasanch, Elisabet [2 ]
Thomas, Sheeba [2 ]
Weber, Donna [2 ]
Orlowski, Robert Z. [2 ]
Champlin, Richard E. [1 ]
Qazilbash, Muzaffar H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
    Srour, Samer A.
    Milton, Denai R.
    Bashir, Qaiser
    Nieto, Yago
    Saini, Neeraj
    Daher, May
    Ramdial, Jeremy
    Im, Jin
    Hosing, Chitra
    Delgado, Ruby
    Manasanch, Elisabet
    Lee, Hans C.
    Thomas, Sheeba
    Kaufman, Gregory
    Patel, Krina
    Popat, Uday
    Weber, Donna
    Orlowski, Robert
    Shpall, Elizabeth
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    HAEMATOLOGICA, 2021, 106 (12) : 3211 - 3214
  • [2] TIMING OF HIGH DOSE MELPHALAN (HDM) AND OUTCOMES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Sobecks, R.
    Pohlman, B.
    Andresen, S.
    Earl, M.
    Dean, R.
    Copelan, E.
    Kalaycio, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 41 - 42
  • [3] Full dose or reduced dose Melphalan (MEL) for autologous stem cell transplantation (ASCT) in multiple myeloma (MM): a single center analysis on 146 patients
    vom Hofe, F.
    Muegge, L-O
    Scholl, S.
    Hilgendorf, I
    Sayer, H.
    Yomade, O.
    Ernst, T.
    Hochhaus, A.
    von Lilienfeld-Toal, M.
    Brioli, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 184
  • [4] Effect of melphalan dose adjustment in multiple myeloma patients undergoing autologous stem cell transplantation
    Gonzalez, A. P.
    Gonzalez, A. J.
    Palomo, P.
    Fernandez, R.
    Pardo, C.
    Alarcon, C.
    Fonseca, A.
    Fonseca, A.
    Gonzalez, S.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S228 - S229
  • [5] High Dose Intravenous Busulfan and Melphalan Followed By Bortezomib (BuMelVel) As Conditioning With Autologous Stem Cell Transplantation (ASCT) For Patients With Multiple Myeloma (MM)
    Sterrenberg, Danielle
    Stiff, Patrick J.
    Parthasarathy, Mala
    Go, Aileen
    Smith, Scott E.
    Rodriguez, Tulio E.
    BLOOD, 2013, 122 (21)
  • [6] High-Dose Therapy (HDT) with Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma
    Brockhoff, Hendrik
    zum Bueschenfelde, Christian Meyer
    Ayoub, Murwan
    Goldschmidt, Hartmut
    Salwender, Hans-Juergen
    BLOOD, 2016, 128 (22)
  • [7] Impact of oral mucositis on outcomes of multiple myeloma patients treated with high-dose melphalan conditioning and autologous stem cell transplantation (ASCT).
    Jaguar, Graziella Chagas
    Rodrigues, Gustavo Henrique
    Guollo, Andre
    Camandoni, Vanessa Oliveira
    Magalhaes, Leila Maria
    Melo, Pessoa
    Alves, Fabio Abreu
    Cordeiro Lima, Vladmir Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [9] Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients
    Brioli, Annamaria
    Felix, vom Hofe
    Muegge, Lars-Olof
    Scholl, Sebastian
    Hilgendorf, Inken
    Sayer, Herbert G.
    Yomade, Olaposi
    Ernst, Thomas
    Hochhaus, Andreas
    von Lilienfeld-Toal, Marie
    BLOOD, 2018, 132
  • [10] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
12345